799 results on '"Locasciulli, A."'
Search Results
2. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
3. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)
4. Long-term density fluctuations and microhabitat use of sympatric Apodemus flavicollis and Myodes glareolus in central Italy
5. Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO)
6. Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
7. Prophylaxis and Treatment of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Results of a Consensus Process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
8. Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation
9. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis
10. Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology
11. Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
12. Non-random distribution across habitat types in sympatric, hardly catchable small mammals at a mountainous site in central Italy
13. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party
14. Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT
15. Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants
16. IMPROVED RELAPSE-FREE SURVIVAL AFTER T-CELL REPLETE HAPLOIDENTICAL BONE MARROW (BM) AND PERIPHERAL BLOOD STEM CELLS (PBSC) TRANSPLANTATION FOLLOWING MYELOABLATIVE CONDITIONING (MAC) AND POST-TRANSPLANTATION CY (PT-CY) IN HIGH-RISK HEMATOLOGIC MALIGNANCIES: PH-P102
17. HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IS A THERAPEUTIC OPTION IN PATIENTS WITH REFRACTORY ACQUIRED SEVERE APLASTIC ANEMIA: A SURVEY BY THE SEVERE APLASTIC ANEMIA WORKING PARTY (SAAWP) AND PAEDIATRIC DISEASES WORKING PARTY (PDWP) OF THE EU: WP-O007
18. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia
19. Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
20. Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection
21. A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia
22. The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia
23. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups
24. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors
25. High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission
26. Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemia
27. Therapeutic decision making in BMT/SCT for severe aplastic anemia
28. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party
29. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT
30. The polymorphisms −318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic anemia in a Caucasian population
31. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party
32. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation
33. Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia
34. HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
35. Acquired Aplastic Anemia in Children: Incidence, Prognosis and Treatment Options
36. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia
37. Il trappolamento come tecnica di ricerca per studi sulle popolazioni dell'istrice: sperimentazione ed osservazioni preliminari nel Parco Regionale Naturale della Maremma
38. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation
39. Therapeutic decision making in BMT/SCT for severe aplastic anemia
40. The Italian Registry of paediatric acquired aplastic anaemia: a retrospective survey: P1179
41. Cyclosporin monitoring at 2 hours from oral intake leads to less toxicity and better efficacy in patients undergoing haematopoietic stem cell transplantation and immunosuppressive treatment for severe aplastic anaemia: P491
42. Outcome of allogeneic HSCT for patients transformed from aplastic anaemia to MDS or leukaemia. A report by the MDS subcommittee of the Chronic Leukaemia Working Party and the Aplastic Anaemia Working Party of the EBMT: O425
43. Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party
44. Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+ 7 after alternative donor transplants
45. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
46. Allogeneic stem cell transplantation following a reducedintensity conditioning regimen in relapsed lymphomas: 5-year follow-up of the phase II study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO): O384
47. Does using a new donor for second haematopoietic stem cell transplantation for patients with Fanconi anaemia influence the outcome? A survey from the EBMT Severe Aplastic Anaemia Working Party: 317
48. Immune response to the 23-valent polysaccharide pneumococcal vaccine (PPV23) after the 7-valent conjugate vaccine (PCV7) in allogeneic stem cell transplant (SCT) recipients: results of the EBMT IDWP01 trial: 323
49. Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the EBMT Severe Aplastic Anaemia Working Party: 315
50. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.